Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Cytokinetics signs research agreement, takes equity stake in MyoKardia

Executive Summary

Cytokinetics Inc. has granted newly formed heart therapeutics company MyoKardia Inc. a license to patents associated with Cytokinetics’ cardiac sarcomere inhibitor program focused on hypertrophic cardiomyopathies.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • R+D and Marketing-Licensing
    • Includes Equity
    • Intra-Biotech Deal

Related Companies

Advertisement
UsernamePublicRestriction

Register